Difference between revisions of "Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211 (Q10116)"
Jump to navigation
Jump to search
(Added reference to claim: Sixth Author string (P154): Calvez V, #quickstatements; #temporary_batch_1590433565826) |
(Added reference to claim: Published In Name String (P102): Clin. Infect. Dis., #quickstatements; #temporary_batch_1590456335858) |
||
| (19 intermediate revisions by the same user not shown) | |||
| Property / Seventh Author string | |||
| + | de Oliveira T | ||
| Property / Seventh Author string: de Oliveira T / rank | |||
| + | Normal rank | ||
| Property / Seventh Author string: de Oliveira T / reference | |||
| + | |||
| Property / Eighth Author string | |||
| + | Dabis F | ||
| Property / Eighth Author string: Dabis F / rank | |||
| + | Normal rank | ||
| Property / Eighth Author string: Dabis F / reference | |||
| + | |||
| Property / Ninth Author string | |||
| + | Porter K | ||
| Property / Ninth Author string: Porter K / rank | |||
| + | Normal rank | ||
| Property / Ninth Author string: Porter K / reference | |||
| + | |||
| Property / Tenth Author string | |||
| + | Pillay D | ||
| Property / Tenth Author string: Pillay D / rank | |||
| + | Normal rank | ||
| Property / Tenth Author string: Pillay D / reference | |||
| + | |||
| Property / Page(s) | |||
| + | 207-214 | ||
| Property / Page(s): 207-214 / rank | |||
| + | Normal rank | ||
| Property / Page(s): 207-214 / reference | |||
| + | |||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1093/cid/ciy881 / rank | |||
| + | Normal rank | ||
| Property / DOI Identifier: 10.1093/cid/ciy881 / reference | |||
| + | |||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 30321314 / rank | |||
| + | Normal rank | ||
| Property / PubMed ID: 30321314 / reference | |||
| + | |||
| Property / Volume | |||
| + | 69 | ||
| Property / Volume: 69 / rank | |||
| + | Normal rank | ||
| Property / Volume: 69 / reference | |||
| + | |||
| Property / title | |||
| + | Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English) | ||
| Property / title: Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English) / rank | |||
| + | Normal rank | ||
| Property / title: Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English) / reference | |||
| + | |||
| Property / Published In Name String | |||
| + | Clin. Infect. Dis. | ||
| Property / Published In Name String: Clin. Infect. Dis. / rank | |||
| + | Normal rank | ||
| Property / Published In Name String: Clin. Infect. Dis. / reference | |||
| + | |||
Latest revision as of 01:27, 26 May 2020
Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211
|
Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)
|
Statements
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English)
